AGILENT TECHNOLOGIES INC (A) Fundamental Analysis & Valuation

NYSE:A • US00846U1016

Current stock price

115 USD
-0.62 (-0.54%)
Last:

This A fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. A Profitability Analysis

1.1 Basic Checks

  • In the past year A was profitable.
  • In the past year A had a positive cash flow from operations.
  • In the past 5 years A has always been profitable.
  • In the past 5 years A always reported a positive cash flow from operatings.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • A has a Return On Assets of 10.07%. This is amongst the best in the industry. A outperforms 91.23% of its industry peers.
  • With an excellent Return On Equity value of 18.67%, A belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
  • A has a Return On Invested Capital of 12.56%. This is amongst the best in the industry. A outperforms 91.23% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for A is above the industry average of 11.01%.
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROIC 12.56%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • A has a better Profit Margin (18.26%) than 87.72% of its industry peers.
  • In the last couple of years the Profit Margin of A has grown nicely.
  • Looking at the Operating Margin, with a value of 22.04%, A belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
  • A's Operating Margin has improved in the last couple of years.
  • A has a better Gross Margin (52.60%) than 64.91% of its industry peers.
  • A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.04%
PM (TTM) 18.26%
GM 52.6%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. A Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), A is creating some value.
  • Compared to 1 year ago, A has less shares outstanding
  • The number of shares outstanding for A has been reduced compared to 5 years ago.
  • Compared to 1 year ago, A has an improved debt to assets ratio.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • A has an Altman-Z score of 4.66. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.66, A belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
  • A has a debt to FCF ratio of 3.38. This is a good value and a sign of high solvency as A would need 3.38 years to pay back of all of its debts.
  • A has a better Debt to FCF ratio (3.38) than 80.70% of its industry peers.
  • A has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • A's Debt to Equity ratio of 0.49 is in line compared to the rest of the industry. A outperforms 40.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Altman-Z 4.66
ROIC/WACC1.18
WACC10.68%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A has a Current Ratio of 2.07. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
  • A has a Current ratio of 2.07. This is in the lower half of the industry: A underperforms 61.40% of its industry peers.
  • A has a Quick Ratio of 1.59. This is a normal value and indicates that A is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.59, A is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
  • A does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.59
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. A Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.03% over the past year.
  • The Earnings Per Share has been growing by 11.21% on average over the past years. This is quite good.
  • A shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.14%.
  • A shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.45% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.09% on average over the next years. This is quite good.
EPS Next Y9.24%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
EPS Next 5Y13.45%
Revenue Next Year6.82%
Revenue Next 2Y6.47%
Revenue Next 3Y6.54%
Revenue Next 5Y8.09%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

5

4. A Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.43 indicates a rather expensive valuation of A.
  • Compared to the rest of the industry, the Price/Earnings ratio of A indicates a rather cheap valuation: A is cheaper than 82.46% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.15. A is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 17.11, the valuation of A can be described as rather expensive.
  • 84.21% of the companies in the same industry are more expensive than A, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.12. A is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.43
Fwd PE 17.11
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 71.93% of the companies in the same industry are more expensive than A, based on the Enterprise Value to EBITDA ratio.
  • 64.91% of the companies in the same industry are more expensive than A, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 32.73
EV/EBITDA 18.46
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)2.21
PEG (5Y)1.82
EPS Next 2Y9.74%
EPS Next 3Y10.3%

5

5. A Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.89%, A is not a good candidate for dividend investing.
  • A's Dividend Yield is rather good when compared to the industry average which is at 0.11. A pays more dividend than 100.00% of the companies in the same industry.
  • With a Dividend Yield of 0.89, A pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.89%

5.2 History

  • On average, the dividend of A grows each year by 6.57%, which is quite nice.
  • A has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.57%
Div Incr Years0
Div Non Decr Years0
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 21.94% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
  • A's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.94%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

A Fundamentals: All Metrics, Ratios and Statistics

AGILENT TECHNOLOGIES INC

NYSE:A (4/28/2026, 11:03:09 AM)

115

-0.62 (-0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners93.64%
Inst Owner Change-0.07%
Ins Owners0.13%
Ins Owner Change4.07%
Market Cap32.50B
Revenue(TTM)7.07B
Net Income(TTM)1.29B
Analysts80
Price Target164.58 (43.11%)
Short Float %1.59%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0.89%
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.94%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.09%
Min EPS beat(2)-2.58%
Max EPS beat(2)-1.6%
EPS beat(4)1
Avg EPS beat(4)-1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.21%
EPS beat(12)8
Avg EPS beat(12)0.61%
EPS beat(16)11
Avg EPS beat(16)1.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)-0.43%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)2.3%
Revenue beat(8)2
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)0.07%
PT rev (1m)-4.12%
PT rev (3m)-3.59%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)0.92%
EPS NY rev (1m)0.25%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)1.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 20.43
Fwd PE 17.11
P/S 4.6
P/FCF 32.73
P/OCF 23.28
P/B 4.7
P/tB 16.27
EV/EBITDA 18.46
EPS(TTM)5.63
EY4.9%
EPS(NY)6.72
Fwd EY5.84%
FCF(TTM)3.51
FCFY3.06%
OCF(TTM)4.94
OCFY4.3%
SpS25
BVpS24.44
TBVpS7.07
PEG (NY)2.21
PEG (5Y)1.82
Graham Number55.6462 (-51.61%)
Profitability
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROCE 14.72%
ROIC 12.56%
ROICexc 14.98%
ROICexgc 32.42%
OM 22.04%
PM (TTM) 18.26%
GM 52.6%
FCFM 14.06%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Debt/EBITDA 1.82
Cap/Depr 142.4%
Cap/Sales 5.7%
Interest Coverage 15.73
Cash Conversion 75.87%
Profit Quality 76.98%
Current Ratio 2.07
Quick Ratio 1.59
Altman-Z 4.66
F-Score6
WACC10.68%
ROIC/WACC1.18
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
EPS Next Y9.24%
EPS Next 2Y9.74%
EPS Next 3Y10.3%
EPS Next 5Y13.45%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%
Revenue Next Year6.82%
Revenue Next 2Y6.47%
Revenue Next 3Y6.54%
Revenue Next 5Y8.09%
EBIT growth 1Y0.19%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year26.25%
EBIT Next 3Y14.67%
EBIT Next 5Y11.62%
FCF growth 1Y-39.78%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-28.81%
OCF growth 3Y5.92%
OCF growth 5Y11.1%

AGILENT TECHNOLOGIES INC / A Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 7 / 10 to A.


Can you provide the valuation status for AGILENT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 5 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


What is the profitability of A stock?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


Can you provide the financial health for A stock?

The financial health rating of AGILENT TECHNOLOGIES INC (A) is 8 / 10.


Can you provide the expected EPS growth for A stock?

The Earnings per Share (EPS) of AGILENT TECHNOLOGIES INC (A) is expected to grow by 9.24% in the next year.